Effects of MF-268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex

Journal of Neuroscience Research

Volumn 43, Issue 1, 1996, Pages 120-126

  Zhu, X D ^a   Cuadra, G ^b   Brufani, M ^c   Maggi, T ^d   Pagella, P G ^d   Williams, E ^a   Giacobini, E ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Mediotanum Farmaceutici SpA   (Italy)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); cholinesterase; dopamine; microdialysis; norepinephrine

Indexed keywords

ACETYLCHOLINE; BIOGENIC AMINE; CHOLINESTERASE INHIBITOR; DOPAMINE; ESEROLINE [8 (2,6 DIMETHYLMORPHOLINO)OCTYL]CARBAMATE TARTRATE; HEPTYLSTIGMINE TARTRATE; MF 268; PHYSOSTIGMINE; SEROTONIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINERGIC SYSTEM; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME INACTIVATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; BIOGENIC AMINES; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; INJECTIONS; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; MORPHOLINES; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0030063146     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.490430116     Document Type: Article

References (24)

1. Auteri A, Mosca A, Lattuada N, Luzzana M, Zecca L, Radice D, Imbimbo BP (1993): Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects. Eur J Clin Pharmacol 45:373-376.
2. Beani L, Tanganelli S, Antonelli T, Bianchi C (1986): Noradrenergic modulation of cortical acetylcholine release is both direct and gamma-aminobutyric acid-mediated. J Pharmacol Exp Ther 236:230-235
3. Becker RE, Moriearty P, Unni L (1991). The second generation of cholinesterase inhibitors: clinical and pharmacological effects. In Becker R. Giacobini E (eds): "Cholinergic Basis for Alzheimer Therapy." Cambridge: Birkhauser Boston, pp 263-296.
4. Beninger RJ (1983): The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173-175.
5. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979): Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-931.
6. Brufani M, Castellano C, Marta M, Oliverio A, Pagella PG, Pavone F, Pomponi M, Rugarli PL (1987): A long-lasting cholinesterase inhibitor affecting neural and behavioral processes. Pharmacol Biochem Behav 26:625-629.
7. Cuadra G, Giacobini E (1995): Co-administration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo. J Pharmacol Exp Ther 273(1):230-240.
8. Cuadra G, Summers K, Giacobini E (1994): Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J Pharmacol Exp Ther 270(1):277-284.
9. Day J, Fibiger HC (1992): Dopaminergic regulation of cortical acetylcholine release. Synapse 12:281-284.
10. Decker MW, McGaugh JL (1991): The role of interactions between cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151-154.
11. DeSarno P, Pomponi M, Giacobini E, Tang XC, Williams E (1989): The effect of heptylphysostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Neurochem Res 14:971-977.
12. Giacobini E, Cuadra G (1994): Second and third generation cholinesterase inhibitors: from preclinical studies to clinical efficacy. In Giacobini E, Becker R (eds): "Alzheimer Disease: Therapeutic Strategies." Cambridge: Birkhauser, pp 155-171.
13. Hallak M, Giacobini E (1986): Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat. Neurochem Res 11(7):1037-1048.
14. Johnson CD, Russell RL (1975): A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal Biochem 64:229-238.
15. Memo M, Missale C, Trivelli L, Spano PF (1988): Acute scopolamine treatment decrease dopamine metabolism in rat hippocampus and frontal cortex. Eur J Pharmacol 149:367-371.
16. Messamore E, Warpman U, Ogane N, Giacobini E (1993): Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology 32(8):745-750.
17. Moroni F, Tanganelli S, Antonelli T, Carlá V, Bianchi C, Beani L (1983): Modulation of cortical acetylcholine and gamma-aminobutyric acid release in freely moving guinea pigs: effects of clonidine and other adrenergic drugs. J Pharmacol Exp Ther 236:230-235.
18. Paxinos G, Watson C (1982): "The Rat Brain in Stereotaxic Coordinates." Sydney: Academic Press.
19. Santucci AC, Haroutunian V, Davis KL (1991): Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats. Clin Neuropharmacol 14:1-7.
20. 3H] acetylcholine on catecholamine and serotonin axons in brain. J Neurochem 42:604-610.
21. Sramek JJ, Block GA, Reines SA, Sawin SF, Barchowsky A, Cutler NR (1995): A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase. Life Sciences 56(5):319-326.
22. Vizi ES (1980): Modulation of cortical release of acetylcholine by noradrenaline released from nerves arising from the rat locus coeruleus. Neuroscience 5:2139-2144.
23. Wise RA (1978): Catecholamine theories of reward: a critical review Brain Res 152:215-219.
24. 2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res 495:232-236